This trial is withdrawn!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Hepatitis, Autoimmune
and you are
between 20 and 70
years old
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

An open-label,prospective, randomized pilot study to evaluate the efficacy, safety and tolerability of paeoniflorin, for the treatment of autoimmune hepatitis (AIH) with mild necroinflammatory activity on liver biopsy.

Provided treatments

  • Drug: Paeoniflorin + phosphatidylcholine or silymarin
  • Drug: Phosphatidylcholine or silymarin

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02878863. The sponsor of the trial is Xiaoli Fan and it is looking for 0 volunteers for the current phase.
Official trial title:
Paeoniflorin Combination of Hepatoprotective Drugs Versus Hepatoprotective Drugs Only for Treatment of Auto-immune Hepatitis